Argenx
ARGX
#551
Rank
โ‚ฌ31.60 B
Marketcap
513,25ย โ‚ฌ
Share price
2.77%
Change (1 day)
45.09%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -3,87ย โ‚ฌ

According to Argenx 's latest financial reports the company's current EPS (TTM) is -3,78ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -11,94ย โ‚ฌ.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-3,87ย โ‚ฌ-67.62%
2022-11,94ย โ‚ฌ